Malformations in offspring of 305 epileptic women: a prospective study
- 29 January 2009
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 85 (3) , 204-207
- https://doi.org/10.1111/j.1600-0404.1992.tb04029.x
Abstract
This paper deals with malformations detected in 26 of 315 newborns of 305 epileptic mothers followed prospectively. In 3 more cases, malformations were detected in utero and therapeutic abortion was performed. Two hundred and seven women were on monotherapy, 102 on polytherapy and 9 were not treated. In total, malformations overall incidence was 9.1%. Minor anomalies were detected in 42 newborns (13.3%). A higher rate of malformations and minor anomalies was found among offspring of mothers treated with valproic acid (VPA). In the VPA group, mothers of malformed babies had higher plasma levels in the first trimester than mothers of babies without malformations. The need for accurate prenatal diagnostic studies in pregnant women with epilepsy is stressed.Keywords
This publication has 12 references indexed in Scilit:
- Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk FactorsEpilepsia, 1988
- Valproic acidTeratology, 1987
- Multi‐institutional Study on the Teratogenicity and Fetal Toxicity of Antiepileptic Drugs: A Report of a Collaborative Study Group in JapanEpilepsia, 1980
- ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTSThe Lancet, 1976
- Epilepsy and Pregnancy: A Report from the Oxford Record Linkage StudyBMJ, 1973
- CONGENITAL MALFORMATION AMONG OFFSPRING OF EPILEPTIC WOMENThe Lancet, 1973
- CONGENITAL MALFORMATIONS AND ANTICONVULSANT DRUGSThe Lancet, 1973
- TERATOGENIC EFFECT OF ANTICONVULSANTSThe Lancet, 1973
- CONGENITAL MALFORMATIONS AMONG INFANTS BORN TO EPILEPTIC WOMENThe Lancet, 1973
- TERATOGENIC EFFECT OF ANTICONVULSANTSThe Lancet, 1972